- Home
- QBTS vs FENC Comparison
QBTS vs FENC Comparison
Compare QBTS & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QBTS
- FENC
- Stock Information
- Founded
- QBTS 1999
- FENC 1996
- Country
- QBTS United States
- FENC United States
- Employees
- QBTS N/A
- FENC N/A
- Industry
- QBTS Retail: Computer Software & Peripheral Equipment
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- QBTS Technology
- FENC Health Care
- Exchange
- QBTS Nasdaq
- FENC Nasdaq
- Market Cap
- QBTS 5.0B
- FENC 229.8M
- IPO Year
- QBTS N/A
- FENC 2001
- Fundamental
- Price
- QBTS $14.65
- FENC $8.34
- Analyst Decision
- QBTS Strong Buy
- FENC Strong Buy
- Analyst Count
- QBTS 6
- FENC 2
- Target Price
- QBTS $12.50
- FENC $13.00
- AVG Volume (30 Days)
- QBTS 54.0M
- FENC 83.2K
- Earning Date
- QBTS 08-07-2025
- FENC 08-12-2025
- Dividend Yield
- QBTS N/A
- FENC N/A
- EPS Growth
- QBTS N/A
- FENC N/A
- EPS
- QBTS N/A
- FENC N/A
- Revenue
- QBTS $21,363,000.00
- FENC $30,912,000.00
- Revenue This Year
- QBTS $181.95
- FENC $0.85
- Revenue Next Year
- QBTS $55.49
- FENC $55.16
- P/E Ratio
- QBTS N/A
- FENC N/A
- Revenue Growth
- QBTS 121.61
- FENC N/A
- 52 Week Low
- QBTS $0.75
- FENC $3.96
- 52 Week High
- QBTS $19.77
- FENC $8.72
- Technical
- Relative Strength Index (RSI)
- QBTS 48.62
- FENC 58.31
- Support Level
- QBTS $13.57
- FENC $7.53
- Resistance Level
- QBTS $15.44
- FENC $8.68
- Average True Range (ATR)
- QBTS 1.08
- FENC 0.49
- MACD
- QBTS -0.48
- FENC -0.04
- Stochastic Oscillator
- QBTS 19.98
- FENC 63.18
About QBTS D-Wave Quantum Inc.
D-Wave Quantum Inc is in the development and delivery of quantum computing systems, software, and services, and it is the commercial supplier of quantum computers and the only company building both annealing quantum computers and gate-model quantum computers. It delivers customer value with practical quantum applications for problems as diverse as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. Its annealing quantum computers are accessible through the company's LeapTM cloud service.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.